Research Article
[Retracted] Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification
Table 3
The diagnostic values of lncRNA FOXD3-AS1 in discriminating lung cancer subtypes.
| Index | AUC | 95% CI | value | Sensitivity | Specificity | Critical value | Yoden index | Down | Up |
| SCLC vs. HS | 0.959 | 0.926 | 0.992 | <0.001 | 88.000 | 92.000 | 0.800 | 3.940 | LUAD vs. HS | 0.763 | 0.670 | 0.855 | <0.001 | 78.000 | 64.000 | 0.420 | 3.195 | LUSC vs. HS | 0.854 | 0.782 | 0.927 | <0.001 | 82.000 | 78.000 | 0.600 | 3.465 | LC vs. HS | 0.859 | 0.802 | 0.915 | <0.001 | 78.000 | 78.000 | 0.560 | 3.465 | SCLC vs. LUAD | 0.888 | 0.822 | 0.953 | <0.001 | 78.000 | 92.000 | 0.700 | 4.375 | SCLC vs. LUSC | 0.821 | 0.737 | 0.905 | <0.001 | 78.000 | 80.000 | 0.580 | 4.380 | LUAD vs. LUSC | 0.658 | 0.552 | 0.765 | 0.006 | 80.000 | 52.000 | 0.320 | 3.535 |
|
|